The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Eng J Med 1995; 333: 1581-1587
Yamaguchi T, Mori E, Minematsu K, et al: Japan Alteplase Clinical Trial (J-ACT) Group. Alteplase at 0.6mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006; 37: 1810-1815
Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 2009; 8(5): 427-433
Shinohara Y, Katayama Y, Uchiyama S, et al, CSPS 2 group: Cilostazol for prevention of secondary stroke (CSPS2): an aspirin-controlled, double-blind, randomized non-inferiority trial. Lancet Neurol 2010; 9(10): 959-968